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Summary
INTRODUCTION
  Limited data on antimicrobial resistance (AMR) in enteric pathogens is available in Kenya 
yet diarrhea remains the main cause of morbidity and mortality among rural Kenyan children.  
 
 There was need to established antimicrobial susceptibility patterns of enteric bacterial 
pathogens to commonly prescribed antibiotics among children aged  <5 years in selected cross-
border Kenyan public hospitals between 2013 and 2016.
METHODOLOGY
 This was a hospital based cross-sectional study. Single stool samples were collected from 
1644 outpatients presenting with diarrhea at Busia, Kitale, Malindi, Wajir, and Machakos public-
hospitals from June 2013 to June 2016 and shipped to Kenya Medical Research Institute (KEMRI). 
Pathogenic E. coli, Shigella and Salmonella sp. were isolated using standard microbiological 
methods. Multiplex Polymerase Chain Reaction (PCR) was used to characterize E. coli isolates. 
Antimicrobial susceptibility testing was done using Kirby Bauer disc diffusion method.
RESULTS
 Out of the 1644 enrolled participants, bacterial pathogens identified were; Pathogenic E. 
coli in 232(14.1%), Shigella in 99 (5.4%) and Salmonella in 49(3.0%). High antimicrobial resistance 
(AMR) levels were observed.  Highest AMR were observed for Sulfamethoxazole (93%) and 
Ampicillin (88%) for E. coli isolates, Sulfamethoxazole (89%) and Ampicillin (88%) for Shigella 
isolates, Sulfamethoxazole (73%) and Ampicillin (86%) for Salmonella isolates. 
 Emerging  resistance at 15%(CI:10-19),  29%(CI:23-35), 1 4%(CI:9-18) for E. coli, 26% 
(CI:18-35), 55%(CI:45-64), 30%(CI:21-39) for Shigella and 31%(CI:18-44), 57%(CI:43-71) 
29%(CI:16-41) for Salmonella were observed to Ciprofloxacin, Nalidixic acid and Gentamycin 
respectively.
CONCLUSION
 Pathogenic E. coli were the most prevalent enteric bacterial pathogens. Highest AMR were 
observed to sulfamethoxazole and ampicillin then emerging resistance to 3rd line antibiotics is of 
a major concern.
[Afr. J. Health Sci.  2019 32(4) : 35 - 42]
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Introduction
 Diarrhea is a significant health problem 
worldwide, especially in the developing world where 
adequate sanitation facilities are lacking [1]. 
 Globally diarrhoeal diseases account for 
almost a fifth of all deaths in children below 5 years, 
with an annual estimate of 2.2 million deaths [2].  
 
 The cause of diarrhea includes an array of 
viruses, parasites and bacteria [3]. The widespread use 
of antimicrobial agents in medical practice and animal 
husbandry has led to serious problems of antimicrobial 
resistance world over [4].
   
 Increasing antimicrobial resistance of enteric 
commensals and pathogens has been a major topic both 
in developed and developing nations for quite a while 
[1]. The emergence and spread of antibiotic resistance 
in enteric pathogens pose a serious problem in Kenya.
This has heightened sense of awareness and interest in 
bacterial diarrheal illnesses [5, 6]. 
 There is a concern on lack of effective treatment 
for drug resistant organisms. This concern has been 
brought about by the recent increase in enteric disease 
outbreaks in Eastern Africa region. 
 Among the enteric pathogens, major drug 
resistant Shigellae sp., Salmonella typhi strains and 
Vibrio cholera spp. have been reported in Kenya [7]. 
 As a result, there is need to determine prevalence 
of these pathogens and their antimicrobial resistance 
profiles along the cross-border points of countries in the 
Eastern Africa region: Kenya, Uganda, and Tanzania. 
 This study aimed at determining the prevalence 
of common circulating enteric bacterial pathogens 
and their antimicrobial susceptibility patterns in select 
cross-border public hospitals in Kenya.
Methodology
Study Design 
 This was a hospital based cross-sectional study 
of all children aged five years and below who sought 
treatment for diarrheal illness from five (5) selected 
cross-border county hospitals in Kenya. These were; 
Busia, Kitale, Wajir, Malindi and Machakos who were 
willing to participate in the study.
Stool Sample Collection 
 The study was granted approval by the 
Scientific Ethics and Review Unit (SERU) at KEMRI. 
After obtaining consent, stool samples were collected 
between June 2013 and June 2016 from 1644 outpatient 
children presenting with diarrhea and were not on 
antibiotics in the last 72 hours. 
 Sample collection was done in sterile plastic 
containers. The specimens were transferred into Cary-
Blair transport media (MML Diagnostics Inc. Troutdale, 
Oregon), labeled only with a unique study number, then 
packaged appropriately (Triple Packaging System) and 
transported to the Kenya Medical Research Institute 
(KEMRI), Nairobi Center for Microbiology Research 
(CMR) laboratories where they were processed. 
Sample Processing
Bacterial Identification
 All stool samples were plated onto MacConkey 
agar, Xylose-Lysine-Deoxycholate agar (XLD) and 
Sorbitol-MacConkey agar, (Oxoid Hampshire, England). 
The plates were incubated aerobically at 37⁰C for 18 to 
24 hours. 
 Thereafter, one to two suspect colonies each 
of Shigella and Salmonella and five to ten colonies 
with typical E. coli morphology were selected and 
characterized on the basis of their biochemical reactions 
[8]. 
Multiplex PCR
 A multiplex PCR assay allowed the detection 
of eleven virulence markers in Pathogenic E. coli. 
Amplification parameters and primers for amplifying 
segments of genes of the Shiga toxins (stx1, stx2, 
and eaeA), Cytotoxin necrotising factors (CNFI and 
CNF2), attaching and effacing mechanisms (eaeA), 
enteroaggregative (EAEC), enteroinvasive mechanism 
(EIEC), and enterotoxigenic (ETEC) detection for heat-
labile (LT) and heat stable (ST1 and ST2) toxins were 
used as described previously [9].
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Antimicrobial Susceptibility Testing
 
 Antimicrobial susceptibility tests were 
conducted using Kirby Bauer disc diffusion method 
[10].  
 The following were commonly used 
antimicrobial agents (Basingstoke Hampshire, 
England). They were tested on all the isolates as per 
CLS guidelines 2016 using E. coli reference strain 











 A total of 1644 participants were enrolled from 
five Kenyan hospitals serving cross-border counties as 
follows: 
 Busia   n    = 291
 Kitale  n    = 492
 Machakos n    = 70 
 Malindi  n    = 387 
 Wajir  n    = 404 
 Among the enrolled participants, etiologies 
of diarrheal were identified in 25.2% (n=415) cases as 
follows: 
 Pathogenic E. coli  14.1%  n   =   232 
 Shigella   5.4%  n   =   99 
 Salmonella   3.0%  n   =   49
Distribution of E. coli pathotypes was: 
 Busia   16.5% 
 Kitale   10%, 
 Machakos  4.3%, 
 Malindi  15%  
 Wajir   18.3% 
while distribution of Shigella was:
 7.6%,  8.9%,  5.7%,  5.2%, and 2.2% 
and that of salmonella was: 
 1.4%,  3%,  0%,  4.9% and 2.7%  
in the five hospitals respectively (Figure 1). 
 Antimicrobial susceptibility testing was 
conducted on:
 48,   49,  3, 58,   and 74 E. coli isolates, 
 22,   44,  4, 20,  and  9  Shigella isolates  
 4,     15, 19, 0     and 11  salmonella isolates 
from Busia, Kitale, Machakos, Malindi and Wajir 
county cross-border hospitals respectively. 
 All the three etiologies of diarrhoeal showed 
resistance to the commonly prescribed antibiotics in 
Kenya though at varied levels. 
 Among the E. coli isolates, overall highest 
levels of resistance were observed in:
 Sulfamethoxazole at  93% (95%      CI:  90-96) 
 Ampicillin            at  88% (95%      CI:  83-92) 
respectively (Table 1). 
 Among Shigella isolates the highest levels of 
resistance were also observed in: 
 Sulfamethoxazole at 89% (95% CI: 69-100) and 
 ampicillin at 88% (95% CI: 81-94) 
respectively (Table 1)
while the highest resistance levels among the Salmonella 
isolates were in:
 ampicillin at 86% (95% CI: 76-96), 
 tetracycline and sulfamethoxazole both at 73%  
 (95% CI: 61-86) (Table 1). 
 Disturbingly, emerging resistance to Nalidixic 
acid, Ciprofloxacin and Gentamycin was also observed 
among the three agents of diarrheal isolated and also at 
each of the cross border hospital. 
Emerging resistance was observed as follows:
E. coli, at:
 29%; (CI:23-35),    15%; (CI:10-19), 
 14%; ( CI:9-18)   
Shigella at: 
 55%;(CI:45-64),     26%; (CI:18-35), 
 30%;(CI:21-39)  
 Salmonella spp.
 57%;(CI:43-71),      31%;(CI:18-44), 
 29%;(CI:16-41)   
(Table 1).
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Table 1: Resistance Profiles Of Enteric Bacterial Pathogens To Commonly Prescribed Antibiotics In The Selected  
























Busia (48) 92(84-100) 25(13-37) 10(2-18) 67(54-80 25(13-37) 21(9-33) 10(2-18) 8(0-16) 98(94-100)
Kitale (49) 92(84-100) 33(20-46) 6(0-13) 78(66-90) 31(18-44) 18(7-29) 12(3-21) 20(9-31) 94(87-100)
Machakos(3)* 100(n/a) 0(n/a) 33(0-86) 67(14-100) 33(0-86) 0(n/a) 0(n/a) 67(14-100) 100(n/a)
Malindi (58) 90(82-98) 31(19-43) 12(4-20) 79(69-89) 29(17-41) 9(2-16) 7(0-14) 10(2-18) 93(86-100)
Wajir (74) 80(71-89) 16(8-24) 24(14-34) 69(58-80) 30(20-40) 11(4-18) 23(13-33) 28(18-38) 89(82-96)
Total(232) 88(83-92) 25(19-31) 15(10-19) 73(67-79) 29(23-35) 14(9-18) 14(9-18) 19(18-24) 93(90-96)
Shigella 
Busia(22) 100(n/a) 27(75-33) 18(2-34) 73(54-92) 59(38-80) 18(2-3) 27(8-46) 18(2-34) 91(79-100)
Kitale(44) 82(71-93) 55(40-70) 25(12-38) 80(68-92) 50(35-65) 25(12-38) 34(20-48) 18(7-29) 84(73-95)
Machakos(4) * 75(33-100) 50(1-99) 50(1-99) 75(33-100) 75(33-100) 50(1-99) 75(33-100) 50(1-99) 100(n/a)
Malindi(20) 90(77-100) 35(14-56) 20(2-38) 85(69-100) 40(19-61) 15(0-31) 20(2-38) 10(0-23) 95(85-100)
Wajir(9) 89(69-100) 33(2-64) 44(12-76) 78(51-100) 89(69-100) 33(2-64) 11(0-31) 44(12-76) 89(69-100)
Total(99) 88(81-94) 42(33-52) 26(18-35) 77(68-85) 55(45-64) 23(15-32) 30(21-39) 21(13-29) 89(83-95)
Salmonella 




100(n/a) 100(n/a) 50(1-99) 75(33-100) 50(1-99) 75(33-100)
Kitale(15) 73(51-95) 13(0-30) 13(0-30) 53(28-78) 27(5-49) 13(0-30) 13(0-30) 27(5-49) 60(35-85)
Malindi(19) 95(85-100) 47(25-69) 26(6-46) 79(61-97) 68(47-89) 32(11-53) 26(6-46) 21(3-39) 84(68-100)
Wajir(11) 82(59-100) 64(36-92) 45(16-74) 82(59-100) 64(36-92) 45(16-74) 36(8-64) 55(26-84) 73(47-99)
Total(49) 86(76-96) 43(29-57) 31(18-44) 73(61-86) 57(43-71) 31(18-44) 29(16-41) 33(20-46) 73(61-86)
Ampicillin (Amp), Chloramphenicol (Chl), Ciprofloxacin(Cip), Tetracycline(Te), Nalidixic acid(Nal), 
Furazolidine(Fur), Gentamycin(Gen), Cefotaxime (Ctx), sulfamethoxazole(Stx).
* Sample size inadquate to interpret resistance
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Discussion
 Antimicrobial resistance (AMR) is a very 
critical healthcare, social and economic problem 
worldwide [11]. 
 In Africa, it seems that same levels of antibiotic 
drug resistance are found in all regions and settings 
yet these regions are widely different in terms of 
Socio - Economic development. Based on published 
reports in Kenya antibiotic resistance has increased 
dramatically in the last 20 years [12]. 
 Despite advances in diagnostic technology 
in some Hospitals in Kenya, many patients receive 
empiric treatment without evidence based laboratory 
identification of the causative agents. 
 Studies done in Kenya among the Maasai 
people fifteen years ago showed a high infection rate of 
Pathogenic E. coli especially in children with diarrhea 
who were under five years of age. Isolates from these 
children showed moderate resistance to antibiotics that 
were used than in treatment of diarrhea where it was 
necessary [13]. 
Figure 1: Distribution In Percentage(%) Of Common Circulating Enteric Bacterial Pathogens In Selected Kenyan  
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 Moreover, the few recently reported studies 
about antimicrobial resistance among diarrheagenic 
E. coli and Shigella strains in children in Kenya show 
a high prevalence rate of resistance to commonly 
prescribed antibiotics for diarrheal illness [5, 14]. 
 In this study, the susceptibilities of 232 
diarrheagenic E. coli, 99 Shigella, 49 Salmonella isolates 
were tested for different antibiotics that are frequently 
prescribed at the study hospitals. In our study, the 
results showed that CIP, NAL, FUR, GEN and CTX had 
moderate activity amongst Shigella isolates. 
 However, previous studies in Kenya, especially 
in Malindi and Narok showed no resistant to these 
drugs [13]. In this case our results indicate an emerging 
resistance to fluoroquinolone (CIP), quinolone (NAL) 
and 3rd generation cephalosporin (CTX).
 Therefore, it is of great concern while these 
antibiotics are used as the last option to treat infections, 
including traveler’s diarrheal. The study showed a 
higher prevalence of resistance to STX, AMP, and 
TE in diarrheagenic E. coli compared to other studies 
elsewhere [14, 16].
 Our study showed pathogenic E. coli as the most 
prevalent with high rates of resistance to AMP, STX 
and TE and moderate resistance was also noted to CHL, 
NAL and CTX, which are the commonly used drugs for 
treatment of diarrhea. Similar rates of resistance have 
been reported, [17, 18, 19]. 
 On the contrary, a study by Vila et al. in 
a neighboring country, Tanzania, displayed high 
susceptibility of pathogenic E. coli to both NAL and 
CIP [20].
 Shigella spp are becoming increasingly resistant 
to most antibiotics commonly used in the treatment of 
diarrhea [21, 22]. In the present study, the prevalence 
of resistance to STX and AMP were similar to those of 
other studies in developing countries [23, 24, 25]. 
 In contrast, the study of Replogle et al. in 
United States showed lower prevalence of resistance of 
Shigella, with 59% resistant to STX and 63% resistant to 
AMP [26]  
 The lower resistance rates to these two 
antibiotics have also been reported by European 
Union in Slovania's summary report on antimicrobial 
resistance [27]. 
 Many studies have reported multi-resistance 
in Shigella especially to STX and AMP, which are 
commonly used to treat Shigellosis [28, 29]. 
In our study, Shigella strains were resistant to:   
 STX       at     89%, 
 AMP      at    88% and 
 TE          at    77%. Except for 
 CHL and 
 NAL 
 that showed moderate activity with Shigella, 
other antibiotics were showing decreased activity 
against this pathogen.
 In this study the percentages of Salmonella 
resistance were:
 AMP       86%, 73% 
 TE,         43% 
 CHL, and 
 STX        73%  
which were quite variable in contrast, with previous 
studies in Kenya that showed the lowest resistance rates 
to:  
 AMP     at   53%, 
 TET      at   59%, 
 CHL     at   36%, and 
 STX      at  53% (5,30).  
 However, the lowest rates from Sri Lanka 
indicate a percentages ranging from 3% (resistance to 
CHL) to 10% (resistance to STX) [28]. 
Conclusion
 In conclusion, the progressive increase 
in antibiotic resistance among enteric pathogens, 
particularly in developing countries, is becoming a 
sensitive concern especially in selecting the appropriate 
treatment for an effective, inexpensive antimicrobial 
agent that can be used safely for treatment of children 
with diarrhea. 
 The immediate concern is knowledge of the 
resistance patterns of enteric pathogens to commonly 
prescribed antibiotics in Kenya.
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